Key takeaways
  • GMP runs on “if it wasn't documented, it didn't happen” - and on data integrity (ALCOA: attributable, legible, contemporaneous, original, accurate).
  • Paper GMP strains on version control, contemporaneous records, completeness, and review burden.
  • Digitizing means enforcing the rules: controlled SOP versions, contemporaneous executable batch records, no skipped fields, and an immutable audit trail.

Good Manufacturing Practice is built on a simple, unforgiving premise: if it wasn't documented, it didn't happen. For small and mid-size pharmaceutical and medical-device manufacturers, that premise turns into mountains of paper - controlled SOPs, batch records, logbooks, training records, deviations - and the constant risk that a single missing signature derails a release or an inspection. This guide covers how to meet FDA and EU GMP expectations by digitizing the work without losing control.

What GMP really demands

Across FDA (21 CFR Parts 210/211 and 820) and EU GMP (EudraLex Volume 4), the core expectations are consistent: documented procedures, trained people following them, contemporaneous records of what was done, controlled changes, and full traceability. The recurring theme is data integrity - records that are attributable, legible, contemporaneous, original, and accurate (the ALCOA principles).

Where paper-based GMP strains

  • Version control. Proving that the operator used the current, approved version of an SOP - and that the superseded one was withdrawn.
  • Contemporaneous records. Batch records completed after the fact, or back-dated, are a data-integrity finding waiting to happen.
  • Legibility and completeness. Blank fields, illegible entries, and missing initials are among the most common 483 observations.
  • Review burden. Manual review of paper batch records is slow, and a single missed entry can hold a release for days.
The data-integrity trap
A back-filled logbook

Inspectors are trained to spot records that were not created contemporaneously - same-pen entries across a week, timestamps that cluster suspiciously, signatures added later. A logbook completed at the end of a shift "to catch up" is not just a process lapse; under current FDA and MHRA expectations it is a data-integrity concern that can escalate far beyond the original gap.

What "digitizing" GMP actually means

Digitizing GMP is not scanning paper into PDFs. It means running controlled procedures and records as a system that enforces the rules paper relies on people to remember:

  • Controlled SOPs. The operator can only execute the current approved version; superseded versions are automatically retired and a full version history is retained.
  • Executable batch records. Steps are completed in sequence, values are captured at the point of action with an automatic timestamp and attributed identity, and the record cannot be completed out of order or back-dated.
  • Enforced completeness. A step cannot be skipped or left blank; a critical out-of-range value triggers a deviation rather than being silently overwritten.
  • Built-in review. Reviewers see exceptions surfaced automatically instead of re-reading every line, turning review-by-exception into the default.
  • Complete audit trail. Every action - who, what, when, and any change - is recorded immutably, satisfying ALCOA by construction.

Start with one process, not the whole quality system

Trying to digitize an entire QMS at once is how these projects stall. Pick a single, high-friction area - a cleaning validation log, a line-clearance procedure, a specific batch record - and run it as a controlled, executable workflow. Prove the model: faster review, cleaner records, a calmer inspection. Then expand.

The inspection difference

The goal is an operation where the record is a by-product of doing the work correctly, not a separate task done afterward. When SOPs are version-controlled, batch records are contemporaneous by design, and every action carries an immutable audit trail, an FDA or notified-body inspection stops being an event you brace for and becomes a demonstration of a system that is in control.

Documented, contemporaneous, attributable, complete - paper can describe those properties, but a well-designed digital workflow enforces them. For a growing pharma or device manufacturer, that enforcement is the difference between scaling cleanly and being held back by your own paperwork.